Marijuana Business Magazine April 2020

Marijuana Business Magazine | April 2020 26 Ignite International Brands . The agreement grants CannMart a license to use certain Ignite brand trademarks on legal cannabis-based products in exchange for royalty payments. Pursuant to the agreement, CannMart will work with Ignite’s quality-control and product-development teams to source flower and other inputs for use in Ignite products. CannMart also assumes all functions associated with procurement, processing and packag- ing of Ignite products and will oversee the sale and dis- tribution of Ignite in Canada. Ignite will market products in Canada on behalf of CannMart. INTERNATIONAL DEVELOPMENTS MJ Firm in Israel Strikes Deal With Nation’s Biggest Drug Store Chain Canndoc, a medical cannabis company owned by Israel-based InterCure , partnered with Israel’s biggest drug store chain, Super-Pharm . Under the terms of the agreement, Super-Pharm committed to acquiring 10 tons of Canndoc’s GMP medical cannabis products over a three-year period. Canndoc’s products will be transferred from its manufacturing facilities to Super-Pharm’s distribution center, which will be responsible for distributing product to its 41 medical cannabis-authorized pharmacies. As part of the partnership, Canndoc will provide Super-Pharm with professional and clinical expertise. Canndoc will begin supplying its products to Super-Pharm immediately. Canndoc also announced a strategic pharmaceutical-grade cannabis commercial deal with Cellect Biotechnology , a publicly traded firm listed on the Nasdaq, for the reduction of opioid usage. Canndoc intends to market its Canndoc-Cellect pharmaceutical-grade cannabis products through its Super-Pharm stores and other distribution channels. New Zealand Grow Raises $12.8 Million Auckland, New Zealand-based Helius Therapeutics raised $12.8 million (20 million New Zealand dollars) to help fund facility expansion and clinical trials. Co-CEO Paul Manning said the fresh round of capital will allow Helius to invest in clinical studies and expand its operations. The New Zealand company signed a memorandum of understanding with two clinical trial groups—Lakeland Clinical Trial Group and Southern Clinical Trial Group—to commence work in the next three months. Helius has plans to double the size of the company’s cultivation facility, which currently sits at 65,000 square feet. Helius is among nearly two dozen companies that are licensed to grow cannabis for research purposes. Amsterdam Seed Provider Partners with PA Grow OG DNA Genetics , a marijuana seed company headquartered in Amsterdam, announced a licensing agreement with PurePenn , a company in McKeesport, Pennsylvania, that grows and produces pharmaceutical-grade cannabis, capsules, concentrates, tinctures, flower and oils. The agreement grants PurePenn a license to the DNA brand, access to its proprietary genetics and standardized operating procedures for their cultivation at the PurePenn cultivation facility. PurePenn’s facility will be comprised of approximately 125,000 square feet of indoor cultivation and production space upon completion of its ongoing expansion efforts. Australian-German Supply Deal Perth, Australia-based Little Green Pharma has signed a binding three-year supply deal with German medicinal cannabis company Demecan . The purchase agreement with Demecan is for any combination of 1,000 kilograms (2,200 pounds) of dried flower or 48,000 units of medical cannabis oil per year. The agreement kicks in with the first commercial shipment, which is expected to take place in the second half of this year. Financial terms were not disclosed. The Australian company also has a deal in place with CC Pharma, a subsidiary of Canadian license holder Aphria and distributor of pharmaceutical products in Germany. Berlin MJ Firm Raises European Record Funding Sanity Group , a medical cannabis and wellness company headquartered in Berlin, has completed what it is calling the largest round of cannabis financing in Europe to date. The round was led by Calyx , a European cannabis-focused investment fund, and HV Holtzbrinck Ventures of Germany, Sanity said in a news release. The cannabis company, founded in 2018, plans to deploy the funds to improve access to medical and medically related cannabis products. Have a company announcement you want us to consider? Send a news release or general information to omars@mjbizdaily.com . (Note: We’re looking for news about expansions, financing, deals, partnerships and similar developments, not product-related announcements.) CompanyNews | U.S., Canada & International